Blocknomi
TLDR Moderna stock plunged more than 17% to $202.63 after early publication of its melanoma vaccine trial results. The Merck-Moderna treatment reduced melanoma recurrence or death risk by 42% and…
Related articles
-
Trader Opens 20x XRP Short With 1,795,706 XRP, Position Sits in Profit
The Crypto Basic Published 08.10.2026 06:29
-
Bitcoin Climbs as Bond Yields, Dollar, and Oil Fall
Crypto Daily Published 13.10.2026 12:31
-
Ripple Partners With Stripe’s Privy to Bring XRP Payments to Apps
Blocknomi Published 14.10.2026 10:12
-
Richard Heart caught ‘off-guard,’ QDay gets even closer: Hodler’s Digest
Cointelegraph Published 18.10.2026 22:58
-
Mastercard Opens AI Agent Payment Tools After Coinbase and Base Pilots
Crypto Daily Published 21.10.2026 17:01
-
The Key Catalyst That Could Unlock Bitcoin’s Next Rally: Analyst
CryptoPotato Published 13.10.2026 11:26
-
Bitcoin monthly ‘new money’ inflows near $5B as BTC price rally stalls
Cointelegraph Published 08.10.2026 09:56
-
Predictfully and nGRND Gold Protocol Secure Massive Engagement Surge in 20-Day Campaign
Blocknomi Published 07.10.2026 11:36